Organisation paid for research Program year 2025 Source: CMS Open Payments

Indiana Univ

Neither a doctor nor a teaching hospital

Research payments

$1,248,684

510 payments

Through program year 2025, Indiana Univ is reported as receiving $1,248,684 in research payments, across 510 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$422,089	21
2024	Research	$146,299	17
2023	Research	$106,464	258
2022	Research	$7,925	2
2021	Research	$51,351	5
2020	Research	$26,550	137
2019	Research	$488,006	70

Breakdown

Who paid Research payments · program years 2019–2025

Janssen Research & Development, LLC $587,448 24 payments
Alcon Research LLC $309,840 4 payments
Novo Nordisk AS $296,271 478 payments
Amgen Inc. $25,628 2 payments
Siemens Medical Solutions USA, Inc. $22,851 1 payment
Boehringer Ingelheim Pharmaceuticals, Inc. $6,645 1 payment

Studies the money was for Research payments · program years 2019–2025

A Phase 1, Multicenter, Open-Label, Dose-Escalation, and Dose-Expansion Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of ARX517 as Monotherapy and in Combination With Androgen Receptor Pathway Inhibitors in Subjects With Metastatic Prostate Cancer $417,640 17 payments
On-Eye Optical Quality of lotrafilcon B Lenses Over 12hrs $205,244 3 payments
Nn9931-4296 $126,375 2 payments
Arx517-2011 $120,019 3 payments
The impact of soft contact lens surface and optics on symptoms associated with digital eye strain in symptomatic soft contact lens wearers $104,596 1 payment
Nn8640-4263 $82,718 382 payments
Nn9924-4437 $58,678 90 payments
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease $49,789 4 payments
Nn9041-4507 $28,500 4 payments
I123 MIBG for therapy assessment in pediatric neuroblastoma $22,851 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.